Acne Medication Market Players:
- Bausch Health Companies Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Mayne Pharma Group Limited
- GlaxoSmithKline Plc.
- Pfizer Inc.
- Mylan N.V.
- Galderma S.A.
- Cosmo Pharmaceuticals SA
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Zydus Lifesciences Limited
- Almirall Sa
- Crown Laboratories
- Nivea
- Sun Pharmaceutical Industries Limited
The acne medication market is quite competitive owing to the presence of established players and the entry of start-ups such as Stryke Club, Derm-Biome Pharmaceuticals, Legit Health, and Dermatica. The key players in the market are mainly focused on the production of advanced medications for acne care, whereas new companies on offering cutting-edge AI-based skin care solutions.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of acne medication is estimated at USD 14.92 billion.
The global acne medication market size was more than USD 14.27 billion in 2025 and is anticipated to grow at a CAGR of around 5.1%, reaching USD 23.47 billion revenue by 2035.
North America acne medication market will account for 48.40% share by 2035, driven by the increasing prevalence of acne and advancements in drug formulation.
Key players in the market include Galderma S.A., Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc., and Pfizer Inc.
